Characteristics of symptom burden in atrial fibrillation with concomitant heart failure
10.1186/s42444-019-0009-9
- Author:
Ran HEO
1
;
Myung‑Jin CHA
;
Tae‑Hoon KIM
;
Jung Myung LEE
;
Junbeom PARK
;
Hyung Wook PARK
;
Ki‑Woon KANG
;
Jaemin SHIM
;
Jae‑Sun UHM
;
Jun KIM
;
Jin‑Bae KIM
;
Changsoo KIM
;
Young Soo LEE
;
Eue‑Keun CHOI
;
Boyoung JOUNG
;
Jin‑Kyu PARK
Author Information
1. Department of Cardiology, Hanyang University Medical Center, Han‑ yang University Seoul Hospital, 222‑1 Wangsimri Road, Seongdong‑gu, Seoul 04763, Republic of Korea
- Publication Type:RESEARCH
- From:International Journal of Arrhythmia
2020;21(1):e1-
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Background:Symptom burden is an important factor in determining the treatment of atrial fibrillation (AF). AF is frequently accompanied by heart failure (HF). This study investigated the characteristics of AF symptoms with concomitant HF.
Methods:A total of 4885 patients with AF were consecutively enrolled through a prospective observational registry (the Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation [CODE-AF] registry). Clinically diagnosed HF was divided into three categories (preserved, mid-range, and reduced ejection fraction [EF]). Symptom severity was assessed using the European Heart Rhythm Association (EHRA) classification.
Results:The presence of AF-related symptoms was comparable irrespective of concomitant HF. Patients with HF with reduced EF demonstrated severe (EHRA classes 3 and 4) and atypical symptoms. HF with preserved EF was also associated with atypical symptoms. Female sex and AF type were associated with the presence of symptoms in AF without HF, and non-maintenance of sinus rhythm and increased left atrial pressure (E/e′ ≥ 15) were factors related to the presence of symptoms in AF with HF.
Conclusion:AF with concomitant HF presented with more severe and atypical symptoms than AF without HF. Maintaining the sinus rhythm and reducing the E/e’ ratio are important factors for reducing symptoms in AF with concomitant HF.
